Connect with us

Technology

Biologit Boosts Patient Safety with World-First Automated Local Literature Monitoring Solution for Non-Indexed Sources

Published

on

* Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable. * The new managed service, already live at a top 10 pharma company, harnesses a technology ingestion model built by Biologit to fill a critical gap in pharmacovigilance, at scale. *Local literature surveillance is a highly resource-intensive mandatory activity, with significant budget implications yet with relative low yield for safety events.

DUBLIN, April 2, 2025 /PRNewswire-PRWeb/ — Biologit, a specialist in advanced, technology-enabled safety surveillance solutions for life sciences, has launched a world-first automation solution for local literature monitoring. Biologit for Local Literature™ solves the costly and complex problem of how to reliably identify adverse events and relevant safety information across the full spectrum of local literature sources, including non-indexed and hard-to-access country-specific publications.

This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now.

The new managed data service, which is already live at a top 10 global biopharma company, fills a critical gap in current international safety surveillance. That’s because a significant proportion of adverse events first come to light via discrete local medical publications and online sources that are not picked up by routine open-source global literature searches. The activity’s critical importance is recognised by regulators, which mandate that pharma companies screen for safety events in all relevant markets.

The traditional screening process for local medical literature is inefficient and unreliable:

Highly manual and time-consuming, it requires dedicated staff at an affiliate or regional level;It yields only limited safety information. Errors and omissions are common;These issues are compounded by inconsistency in the format, indexing; access issues (e.g. paid subscriptions/print-only formats); language barriers; and variances in regulators’ reporting expectations.

Biologit for Local Literature uses advanced technology to overcome this challenge, efficiently, reliably and at scale. It has been shown to yield a 15-fold acceleration in safety event reporting when applied to a broad spectrum of local sources across 30 EU countries, with impressive accuracy.

Optimised algorithms, closely governed

Biologit for Local Literature uses a technology-based ingestion model developed by Biologit’s expert engineers. Each source is evaluated, and proprietary technology methods (including optimised algorithms that act as automated ‘crawlers’ per site) are used to support the ingest of any non-indexed in-country literature source as required. Even hard-to-reach print sources, conference proceedings and websites are included. As part of the managed service, Biologit’s operations team then confirms the findings manually, balancing process innovation with strong governance to contain any risk and ensure the product is audit-ready.

This innovative solution complements the company’s existing Biologit Database™, an extensive and continuously updated range of indexed, open-source global, regional and national medical publications and online resources. The ability to screen more diverse, non-standardised local sources in a reliable and highly efficient way – and filter searches by country – via Biologit’s new bespoke managed data service, rounds off the solution suite.

The combined 360-degree screening is powered by Biologit Platform™, Biologit’s powerful scientific literature monitoring platform, which features flexible workflow and unique AI productivity features. Biologit for Local Literature removes the final source of pain and risk from literature monitoring, raising the overall benefit to patient safety. ALL safety events are accessible via a single window, or query.

Delivered via the Biologit Platform, Biologit for Local Literature covers all countries and includes automated machine translation for hundreds of languages. The innovative technology allows for country-level data filtering for specific local searches, and individual country reporting and audit trails. It also supports single, integrated searches for global and local safety events.

Commenting on the significance of Biologit for Local Literature, Nicole Baker, Biologit’s CEO and co-founder, said:

“This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now. Worse than that, it hasn’t delivered. This world-first, tech-enabled managed service ensures accurate and complete coverage for all journals, websites and subscription-based publications of interest in a country, delivered with unprecedented efficiency.

“Our use of automation allows us to do this at scale. This is not about assigning large service teams, or trying to track everything in spreadsheets. With Biologit for Local Literature we harness technology including specially-developed crawlers which are fast and reliable, and everything is properly overseen by our skilled people, to verify the accuracy and reliability of the output. Given the high sensitivity of patient safety, and the strict PV/Regulatory requirements, we have taken great pains to balance innovation and risk, and the results are exceeding all expectations.”

A new white paper, A World First: Integrated, Automated Global & Local Literature Monitoring for Pharmacovigilance is available for download on the Biologit website here. To arrange a 1:1 demonstration please email jean.redmond@biologit.com.

About Biologit

Biologit is an innovator in pharmacovigilance (PV), revolutionising the way that life science organisations handle literature review and monitoring, using cutting-edge automation technology wherever appropriate. Founded with a mission to enhance patient safety and operational efficiency, Biologit empowers pharmaceutical, biotech and PV service providers to simplify and streamline their processes. At the heart of Biologit’s Platform is its AI-powered literature automation tool, designed to transform manual and time-intensive tasks into seamless, efficient workflows. Biologit adheres to the highest industry standards, including ISO 27001 certification, GxP compliance, and alignment with FDA regulations.

PR Contact

Carina Birt, Sarum Life Sciences

carina@sarumlifesciences.com

+44 7970 006624

Media Contact

Jean Redmond, biologit, 44 00000000000, jean.redmond@biologit.com, https://www.biologit.com/

View original content:https://www.prweb.com/releases/biologit-boosts-patient-safety-with-world-first-automated-local-literature-monitoring-solution-for-non-indexed-sources-302417543.html

SOURCE biologit

Continue Reading

Technology

Canton Fair Buyers Alliance Launched as the 140th Edition Opens

Published

on

By

GUANGZHOU, China, Oct. 17, 2026 /PRNewswire/ — On October 15, the Canton Fair Buyers Alliance was officially launched at the Canton Fair Complex, marking a significant milestone as the fair celebrates the 70th anniversary of its founding.

More than 140 overseas buyers attended the launch ceremony, highlighting the fair’s enduring role as a bridge connecting global commerce with China’s export sector.

Speaking at the ceremony, Luís Vilariça, CEO of Joinco, Import & Export, Ltd., discussed his company’s long-standing relationship with the Canton Fair. Drawing on years of participation, he reflected on the growth opportunities created through cooperation with Chinese suppliers and highlighted the fair’s role in supporting international business development and global trade exchanges.

The ceremony also featured a joint declaration by alliance members. Representatives from five member companies read the statement in their respective native languages, underscoring the international character of the new organization. Additional members sent video congratulatory messages, joining the celebration and witnessing the official launch of the alliance.

The Canton Fair Buyers Alliance represents one of the fair’s key service innovations. Designed primarily for Fortune Global 500 companies, buyers from the world’s top 250 retailers and leading sourcing enterprises across a diverse range of markets, the alliance aims to offer members a platform for information sharing and resource coordination. The first cohort of alliance members includes 58 companies from 32 countries and regions across 5 continents. Through the alliance, members will gain access to a range of priority benefits spanning four major areas: services, events, resources and information.

 For more convenient attendance, please click here for pre-registration:

https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

View original content to download multimedia:https://www.prnewswire.com/news-releases/canton-fair-buyers-alliance-launched-as-the-140th-edition-opens-302911896.html

SOURCE Canton Fair

Continue Reading

Technology

Bioethanol from human hair – Indian start-up’s solution to rising prices of grains and sugar

Published

on

By

GUJARAT, India, Oct. 17, 2026 /PRNewswire/ — In what could be called the beginning of the 5G (fifth-generation) of bioethanol or non-cellulosic bioethanol or non-sugar-based biofuels, an Indian start-up, Techofest Global, based out of Gujarat, has developed its own, indigenous, and patented technology for the production of bioethanol from waste human hair. Such processes would significantly reduce the employment of sugars, grains, and agricultural residues, which form the classical first- and second-generation bioethanol feedstocks. As a result, the rising fuel-vs.-food/fodder debate is anticipated to reduce, and instead, ethanol produced from municipal/industrial waste, after trials, can supplement the current supply being used as blends with presently retailed fossil fuels (E20, E27, etc.). 

As stated by Dr. Ravi, the founder-CEO of Techofest Global, the strategic priority and the USP of the start-up is industrial symbiosis, which, typically, involves an ecosystem of up-cycling/valorising the effluents of an industry, thereby creating a value-chain for residues often lacking an end-of-life. With more than three decades of experience in designing customized nuclear fusion reactors for international programmes, such as ITER, JET/UKAEA and SST-1, Dr. Ravi, a seasoned mechanical engineer, spearheads the start-up’s patented technologies’ scale-up and commercialization.

Two biochemical engineers, Dr. Navnit – the former CTO, and Dr. Kabilan – the former CEO of Biomakerz, Chennai, are the brains behind the current technology/process portfolio of the joint-venture between Techofest Global and Biomakerz. They have been working on biorefineries’ process intensification for more than a decade. “Having foreseen the fuel-vs-fodder/food competition as early as the year 2015, we began developing techno-economically feasible and viable in-vitro metabolically-engineered bioprocesses for scaling-up ethanol production from municipal waste streams between 2019–2021”, says Navnit. After developing operational technologies for international biofuel organizations, serving process engineer roles with certain biorefineries-related OMC R&D’s of India, Dr. Navnit, presently works for a premier academic institution.

An on-going fermentation trial at the Techofest Global-Biomakerz JV’s R&D facility

Techofest Global has developed and tested, in its R&D JV’s pilot-facility of ~100-L, 3 innovative and cost-effective technologies, such as 5G ethanol production using human hair, used cooking oil (UCO), and enriched bio-methane production from disposed sanitary napkins.

“With massive CapEx and OpEx, 2G ethanol technology is facing a major commercialization bottleneck, owing to competition with food/livestock fodder, requirement of a cost-intensive pre-treatment procedure, and the requirement of cellulolytic cocktails, which have a poor recycle efficiency. The proprietary 5G SAFE process developed for the start-up circumvents the mentioned constraints, and instead, utilizes a single-stage saccharification followed by fermentation, and records over 85–90% biocatalyst recovery. Likewise, the proprietary SIM process for bio-methane production, exclusively developed for the start-up, is 2x faster with improved intermittent feeding cycles and continuous gas harvest”, says Navnit.

“With on-going pre-commercialization trials, the proprietary ethanol and bio-methane processes of ours are soon being commercialized”, says Ms. Bhumika, the co-founder and the corporate advisor of the start-up. Furthermore, Mr. Ronak pilots the organization’s global market entry and commercialization frontier.

Techofest Global’s veteran Principal Technology Advisors include: Dr VS Tripathi, former Joint Director, DRDE Gwalior, Dr B S Munjal, former Director, Structures and Thermal group, SAC/ISRO, Academician and Advisor CIKS-Dharohar, GTU, and Dr AV Santhanababu, former Scientist at Satish Dhawan Space Centre. With on-going R&D activities, Dr. Munjal says, “the start-up is striving to provide a unique solution along the lines of the Atmanirbhar and Viksit Bharat Vision 2047”.

Media Contact: www.techofestglobal.com; e-mail: info@techofestglobal.com; contact person: The PR team of Techofest Global.

Photo: https://mmx.prnewswire.com/media/MS2015507/Picture1.jpg?id=OA3024965&token=5vT9XuZXAG0yamsZlRrsBAiUapaplm73wYH8NIfU0xCtOlj76dueXcTw2Eb-3w

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/bioethanol-from-human-hair–indian-start-ups-solution-to-rising-prices-of-grains-and-sugar-302911813.html

Continue Reading

Technology

As AI Speeds Up Marketing, Louisville’s RedTag Bets on Strategy

Published

on

By

Independent agency unveils new brand and website, and co-hosts Louisville’s PROOF AI Workshop

LOUISVILLE, Ky., Oct. 17, 2026 /PRNewswire/ — RedTag, an independent Louisville-based marketing agency, this month unveiled new positioning, marking its evolution from a digital performance agency into a strategy-first marketing partner. The move comes as AI makes execution faster than ever, and RedTag is betting that strategy, not speed, is what will set businesses apart. Clients can now choose from outcome-based programs that best fit their marketing needs. 

“Clients don’t come to us needing more tactics. They come to us needing a path,” said Russ Renbarger, founder and CEO of RedTag. “Our new brand says out loud what our work has shown for years: We start with strategy and build everything on that foundation.”

RedTag built its reputation on high-performing paid digital campaigns. Over the years, the agency expanded into strategy, creative, video production and website development, giving clients one partner for the full scope of their marketing. Most recently, a team of automation specialists has integrated AI across the agency to speed up production and analysis, guided by an internal AI policy that keeps people accountable for quality. The time AI saves goes back into strategy: knowing what to say, who to say it to and why.

“Our best client relationships have always been partnerships, where we’re in the room when the big decisions get made,” said Alison Conway, chief client officer at RedTag. “This evolution is about bringing that strategic partnership to every client.”

On Oct. 14, RedTag co-hosted the PROOF AI Workshop with Slingshot, Vsimple and Advanced Business Solutions. The hands-on event gave Louisville business leaders practical experience applying AI to their own work. RedTag led the event’s AI in Marketing and Branding track, with four sessions ranging from AI search optimization to a playbook for adopting AI across an organization.

“AI can produce hundreds of ads in an afternoon, but it can’t tell you which one your brand actually needs and why,” Renbarger said. “The faster the tools get, the more valuable human-led strategy becomes.”

RedTag was named the agency of record for the Commonwealth of Kentucky in 2025. Its client list includes PGA of America, Castle & Key Distillery, Bourbon Barrel Foods, ShopCaterpillar and American Beverage Marketers. Since 2023, RedTag’s work has received two Emmy Awards and more than 35 ADDY and AIGA awards. The agency is a four-time Louisville Business First Fast 50 honoree and was named one of the 2026 Best Places to Work in Kentucky.

To learn more about its outcome-based programs, visit RedTag Programs

About RedTag

RedTag is an independent, strategy-first marketing agency based in Louisville, Kentucky. Established in 2008, the agency starts every engagement by understanding the goal before recommending tactics. With a foundation rooted in discovery, RedTag delivers full-scale marketing campaigns built around each client’s business goals. RedTag serves organizations across hospitality, sports, agriculture, government, retail and consumer packaged goods. Learn more at redtag.agency.

View original content to download multimedia:https://www.prnewswire.com/news-releases/as-ai-speeds-up-marketing-louisvilles-redtag-bets-on-strategy-302911869.html

SOURCE RED TAG LLC

Continue Reading

Trending